Articles dans des revues avec comité de lecture (60)

  1. 49. Fontaine, V., Mahieu, M., & Content, J. (1998). Interferon-gamma and interleukin-6 inhibit proliferation in human melanoma cells by different signalling pathways. Melanoma research, 8(1), 24-30.
  2. 50. Kalai, M., Montero-Julian, F. A., Brakenhoff, J. P., Fontaine, V., De Wit, L., Wollmer, A., Brailly, H., Content, J., & Grötzinger, J. (1997). Analysis of the mechanism of action of anti-human interleukin-6 and anti-human interleukin-6 receptor-neutralising monoclonal antibodies. European journal of biochemistry / FEBS, 249(3), 690-700. doi:10.1111/j.1432-1033.1997.t01-2-00690.x
  3. 51. Kalai, M., Montero-Julian, F. A., Grötzinger, J., Fontaine, V., Vandenbussche, P., Deschuyteneer, R., Wollmer, A., Brailly, H., & Content, J. (1997). Analysis of the human interleukin-6/human interleukin-6 receptor binding interface at the amino acid level: proposed mechanism of interaction. Blood, 89(4), 1319-1333.
  4. 52. Fontaine, V., Rasschaert, J., Content, J., & Malaisse, W. (1996). Effect of succinic acid monomethyl ester on interleukin-1β cytotoxicity in tumoural pancreatic islet cells. Medical science research, 24(8), 549-551.
  5. 53. Kalai, M., Montero-Julian, F. A., Grötzinger, J., Fontaine, V., Deschuyteneer, R., Wollmer, A., Brailly, H., Content, J., & Vandenbussche, P. (1996). The IL-6/IL-6R binding interface. proposed mechanism of interaction. Archives of physiology and biochemistry, 104, B13.
  6. 54. Fontaine, V., Ooms, J., & Content, J. (1994). Mutagenesis of the human interleukin-6 fourth predicted alpha-helix: involvement of the Arg168 in the binding site. European Journal of Immunology, 24(5), 1041-1045. doi:10.1002/eji.1830240505
  7. 55. Brakenhoff, J. P., de Hon, F. D., Fontaine, V., ten Boekel, E., Schooltink, H., Rose-John, S., Heinrich, P. C., Content, J., & Aarden, L. A. (1994). Development of a human interleukin-6 receptor antagonist. The Journal of biological chemistry, 269(1), 86-93.
  8. 56. Fontaine, V., Savino, R., Arcone, R., de Wit, L., Brakenhoff, J. P., Content, J., & Ciliberto, G. (1993). Involvement of the Arg179 in the active site of human IL-6. European journal of biochemistry / FEBS, 211(3), 749-755.
  9. 57. Arcone, R., Fontaine, V., Coto, I., Brakenhoff, J. P., Content, J., & Ciliberto, G. (1991). Internal deletions of amino acids 29-42 of human interleukin-6 (IL-6) differentially affect bioactivity and folding. FEBS letters, 288(1-2), 197-200.
  10. 58. Fontaine, V., Brakenhoff, J. P., de Wit, L., Arcone, R., Ciliberto, G., & Content, J. (1991). Internal deletions in human interleukin-6: structure-function analysis. Gene, 104(2), 227-234.
  11. 59. Arcone, R., Pucci, P., Zappacosta, F., Fontaine, V., Malorni, A., Marino, G., & Ciliberto, G. (1991). Single-step purification and structural characterization of human interleukin-6 produced in Escherichia coli from a T7 RNA polymerase expression vector. European journal of biochemistry / FEBS, 198(3), 541-547.
  12. 60. Snyers, L., Fontaine, V., & Content, J. (1989). Modulation of interleukin-6 receptors in human cells. Annals of the New York Academy of Sciences, 557, 388-395. doi:10.1111/j.1749-6632.1989.tb24031.x

  13. << Précédent 1 2 3 4 5 6 7 8 9 10 Suivant >>